The candidate NRGs were all highly expressed in thyroid cancer tissues, and candidate neoantigen genes, such as CDH6, ODZ1, and PROS1, were significantly differentially expressed in thyroid cancers. This evidence concerns the gene TENM1 and thyroid gland carcinoma.